Are you Dr. John Anthony Garofalo MD?
Claim this Profile
Dr. John Anthony Garofalo MD, Hematologist-Oncologist

Dr. John Anthony Garofalo MD

Hematologist-Oncologist | Hematology & Oncology

847 Old Lancaster Road Bryn Mawr PA, 19010



Dr. John Garofalo is a hematologist oncologist practicing in Bryn Mawr, PA. Dr. Garofalo specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.

Education and Training

Univ Di Roma-La Sapienza, Fac Di Med E Chirurgia, Roma, Italy 1974

University of Roma-La Sapienza / Faculty of Medicine And Surgery 1974

Provider Details

Male English 37 years of experience


  • Mem Sloan-Kettering Cancer Ctr, Medical Oncology; Pa Hospital-Uphs, Internal Medicine; Philadelphia Gen Hosp, Internal Medicine
  • Mem Sloan Kettering Cancer Center

Accepted Insurance

+ See all 2 Insurance

Dr. John Anthony Garofalo MD's Practice location

Dr. John Garofalo, MD

847 Old Lancaster Road -
Bryn Mawr, PA 19010
Get Direction
New patients: 610-527-1290, 610-527-1290
Fax: 610-527-0979, 610-527-0979

Request An Appointment With Dr. John Anthony Garofalo MD | Hematologist-Oncologist | Hematology & Oncology

Please note that this request is not considered final until you receive email notification confirming the details.

In the event the doctor is not yet registered with FindaTopDoc, we will contact the office on your behalf in an effort to secure your appointment.

Dr. John Anthony Garofalo MD's reviews

Write Review

Patient Experience with Dr. Garofalo


Based on 3 reviews

Dr. John Anthony Garofalo MD has a rating of 4 out of 5 stars based on the reviews from 3 patients. FindaTopDoc has aggregated the experiences from real patients to help give you more insights and information on how to choose the best Hematologist-Oncologist | Hematology & Oncology in your area. These reviews do not reflect a providers level of clinical care, but are a compilation of quality indicators such as bedside manner, wait time, staff friendliness, ease of appointment, and knowledge of conditions and treatments.
Be the first to leave a review

Recommended Articles

  • The Lymphoma Research Foundation Announces Partnership with the Annals of Lymphoma

    The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization for lymphoma research, and they just announced their partnership with the Annals of Lymphoma (AOL). This was all revealed in September during Blood Cancer Awareness Month. LRF is devoted to exclusively funding...

  • Superheroes Unite For Elementary Student Fighting Lymphoma

    Anyone diagnosed with cancer knows how terrifying and debilitating the news can be. Now just imagine how horrible an experience it would be for an elementary school student to hear that they have cancer.It is a sad fact that thousands of children are diagnosed with cancer every year, and it is...

  • The Effect of Sunshine on Lymphoma

    Having a lack of enough vitamin D can drastically effect one's ability to fight many cancers, including lymphoma. So, researchers inevitably wondered whether the addition of Vitamin D to preexisting therapies would prolong patients' lives. The Wilmot Cancer Institute received a $3 million grant for...

  • Tips for Young Adult Lymphoma Survivors to Make the Most of Recovery

    It is extremely difficult to reenter the world and normal life after battling lymphoma. Recovery is much more than the body's physical battle, but how to balance emotions and relationships as well.However, there are specific tools that can assist in adapting back into a life that may seem...

  • How is Multiple Myeloma Diagnosed?

    Various tests are conducted for the diagnosis of multiple myeloma since one result of a laboratory test cannot diagnose it alone. A number of factors like the history, complete body check-up, diagnostic test reports and symptoms of the patient are taken into consideration to get a proper diagnosis...

  • Promising Results for Hodgkin Patients Using This Therapy

    Researcher Dr. Bradford S. Hoppe and his colleagues at the University of Florida College of Medicine have recently found that the addition of proton therapy to first-line chemotherapy regimens may improve outcomes for patients with Hodgkin lymphoma.Lymphoma is classically treated with both...

Nearby Hematologist-Oncologists